世界の成長/分化係数8市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Growth/Differentiation Factor 8 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5763 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、成長/分化係数8の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他）、用途別市場規模（ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・成長/分化係数8の市場動向 ・企業の競争状況、市場シェア ・成長/分化係数8の種類別市場規模と予測2016-2027（OSX-200、SRK-015、ACE-2494、ACE-2798、BMS-986089、その他） ・成長/分化係数8の用途別市場規模と予測2016-2027（ベッカー筋ジストロフィー、線維症、骨髄線維症、鎌状赤血球症、その他） ・成長/分化係数8の北米市場規模2016-2027（アメリカ、カナダ） ・成長/分化係数8の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・成長/分化係数8のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・成長/分化係数8の中南米市場規模2016-2027（メキシコ、ブラジル） ・成長/分化係数8の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Acceleron Pharma, Inc.、Atara Biotherapeutics, Inc.、Bristol-Myers Squibb Company、Eli Lilly and Company、Milo Biotechnology LLC、Pfizer Inc.、Regeneron Pharmaceuticals, Inc.、Sarepta Therapeutics, Inc.、Scholar Rock, Inc.） ・結論

Market Analysis and Insights: Global Growth/Differentiation Factor 8 Market
The global Growth/Differentiation Factor 8 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Growth/Differentiation Factor 8 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Growth/Differentiation Factor 8 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Growth/Differentiation Factor 8 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Growth/Differentiation Factor 8 market.

Global Growth/Differentiation Factor 8 Scope and Market Size
Growth/Differentiation Factor 8 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Growth/Differentiation Factor 8 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OSX-200
SRK-015
ACE-2494
ACE-2798
BMS-986089
Others

Segment by Application
Becker Muscular Dystrophy
Fibrosis
Myelofibrosis
Sickle Cell Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acceleron Pharma, Inc.
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Milo Biotechnology LLC
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc.
Scholar Rock, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Growth/Differentiation Factor 8 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OSX-200
1.2.3 SRK-015
1.2.4 ACE-2494
1.2.5 ACE-2798
1.2.6 BMS-986089
1.2.7 Others
1.3 Market by Application
1.3.1 Global Growth/Differentiation Factor 8 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Becker Muscular Dystrophy
1.3.3 Fibrosis
1.3.4 Myelofibrosis
1.3.5 Sickle Cell Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Growth/Differentiation Factor 8 Market Perspective (2016-2027)
2.2 Growth/Differentiation Factor 8 Growth Trends by Regions
2.2.1 Growth/Differentiation Factor 8 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Growth/Differentiation Factor 8 Historic Market Share by Regions (2016-2021)
2.2.3 Growth/Differentiation Factor 8 Forecasted Market Size by Regions (2022-2027)
2.3 Growth/Differentiation Factor 8 Industry Dynamic
2.3.1 Growth/Differentiation Factor 8 Market Trends
2.3.2 Growth/Differentiation Factor 8 Market Drivers
2.3.3 Growth/Differentiation Factor 8 Market Challenges
2.3.4 Growth/Differentiation Factor 8 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Growth/Differentiation Factor 8 Players by Revenue
3.1.1 Global Top Growth/Differentiation Factor 8 Players by Revenue (2016-2021)
3.1.2 Global Growth/Differentiation Factor 8 Revenue Market Share by Players (2016-2021)
3.2 Global Growth/Differentiation Factor 8 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Growth/Differentiation Factor 8 Revenue
3.4 Global Growth/Differentiation Factor 8 Market Concentration Ratio
3.4.1 Global Growth/Differentiation Factor 8 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Growth/Differentiation Factor 8 Revenue in 2020
3.5 Growth/Differentiation Factor 8 Key Players Head office and Area Served
3.6 Key Players Growth/Differentiation Factor 8 Product Solution and Service
3.7 Date of Enter into Growth/Differentiation Factor 8 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Growth/Differentiation Factor 8 Breakdown Data by Type
4.1 Global Growth/Differentiation Factor 8 Historic Market Size by Type (2016-2021)
4.2 Global Growth/Differentiation Factor 8 Forecasted Market Size by Type (2022-2027)

5 Growth/Differentiation Factor 8 Breakdown Data by Application
5.1 Global Growth/Differentiation Factor 8 Historic Market Size by Application (2016-2021)
5.2 Global Growth/Differentiation Factor 8 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Growth/Differentiation Factor 8 Market Size (2016-2027)
6.2 North America Growth/Differentiation Factor 8 Market Size by Type
6.2.1 North America Growth/Differentiation Factor 8 Market Size by Type (2016-2021)
6.2.2 North America Growth/Differentiation Factor 8 Market Size by Type (2022-2027)
6.2.3 North America Growth/Differentiation Factor 8 Market Size by Type (2016-2027)
6.3 North America Growth/Differentiation Factor 8 Market Size by Application
6.3.1 North America Growth/Differentiation Factor 8 Market Size by Application (2016-2021)
6.3.2 North America Growth/Differentiation Factor 8 Market Size by Application (2022-2027)
6.3.3 North America Growth/Differentiation Factor 8 Market Size by Application (2016-2027)
6.4 North America Growth/Differentiation Factor 8 Market Size by Country
6.4.1 North America Growth/Differentiation Factor 8 Market Size by Country (2016-2021)
6.4.2 North America Growth/Differentiation Factor 8 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Growth/Differentiation Factor 8 Market Size (2016-2027)
7.2 Europe Growth/Differentiation Factor 8 Market Size by Type
7.2.1 Europe Growth/Differentiation Factor 8 Market Size by Type (2016-2021)
7.2.2 Europe Growth/Differentiation Factor 8 Market Size by Type (2022-2027)
7.2.3 Europe Growth/Differentiation Factor 8 Market Size by Type (2016-2027)
7.3 Europe Growth/Differentiation Factor 8 Market Size by Application
7.3.1 Europe Growth/Differentiation Factor 8 Market Size by Application (2016-2021)
7.3.2 Europe Growth/Differentiation Factor 8 Market Size by Application (2022-2027)
7.3.3 Europe Growth/Differentiation Factor 8 Market Size by Application (2016-2027)
7.4 Europe Growth/Differentiation Factor 8 Market Size by Country
7.4.1 Europe Growth/Differentiation Factor 8 Market Size by Country (2016-2021)
7.4.2 Europe Growth/Differentiation Factor 8 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Growth/Differentiation Factor 8 Market Size (2016-2027)
8.2 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Type
8.2.1 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Type (2016-2027)
8.3 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Application
8.3.1 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Application (2016-2027)
8.4 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Region
8.4.1 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Growth/Differentiation Factor 8 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Growth/Differentiation Factor 8 Market Size (2016-2027)
9.2 Latin America Growth/Differentiation Factor 8 Market Size by Type
9.2.1 Latin America Growth/Differentiation Factor 8 Market Size by Type (2016-2021)
9.2.2 Latin America Growth/Differentiation Factor 8 Market Size by Type (2022-2027)
9.2.3 Latin America Growth/Differentiation Factor 8 Market Size by Type (2016-2027)
9.3 Latin America Growth/Differentiation Factor 8 Market Size by Application
9.3.1 Latin America Growth/Differentiation Factor 8 Market Size by Application (2016-2021)
9.3.2 Latin America Growth/Differentiation Factor 8 Market Size by Application (2022-2027)
9.3.3 Latin America Growth/Differentiation Factor 8 Market Size by Application (2016-2027)
9.4 Latin America Growth/Differentiation Factor 8 Market Size by Country
9.4.1 Latin America Growth/Differentiation Factor 8 Market Size by Country (2016-2021)
9.4.2 Latin America Growth/Differentiation Factor 8 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Growth/Differentiation Factor 8 Market Size (2016-2027)
10.2 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Type
10.2.1 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Type (2016-2027)
10.3 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Application
10.3.1 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Application (2016-2027)
10.4 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Country
10.4.1 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Growth/Differentiation Factor 8 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acceleron Pharma, Inc.
11.1.1 Acceleron Pharma, Inc. Company Details
11.1.2 Acceleron Pharma, Inc. Business Overview
11.1.3 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Introduction
11.1.4 Acceleron Pharma, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.1.5 Acceleron Pharma, Inc. Recent Development
11.2 Atara Biotherapeutics, Inc.
11.2.1 Atara Biotherapeutics, Inc. Company Details
11.2.2 Atara Biotherapeutics, Inc. Business Overview
11.2.3 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Introduction
11.2.4 Atara Biotherapeutics, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.2.5 Atara Biotherapeutics, Inc. Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Growth/Differentiation Factor 8 Introduction
11.4.4 Eli Lilly and Company Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.4.5 Eli Lilly and Company Recent Development
11.5 Milo Biotechnology LLC
11.5.1 Milo Biotechnology LLC Company Details
11.5.2 Milo Biotechnology LLC Business Overview
11.5.3 Milo Biotechnology LLC Growth/Differentiation Factor 8 Introduction
11.5.4 Milo Biotechnology LLC Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.5.5 Milo Biotechnology LLC Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Growth/Differentiation Factor 8 Introduction
11.6.4 Pfizer Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.6.5 Pfizer Inc. Recent Development
11.7 Regeneron Pharmaceuticals, Inc.
11.7.1 Regeneron Pharmaceuticals, Inc. Company Details
11.7.2 Regeneron Pharmaceuticals, Inc. Business Overview
11.7.3 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Introduction
11.7.4 Regeneron Pharmaceuticals, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
11.8 Sarepta Therapeutics, Inc.
11.8.1 Sarepta Therapeutics, Inc. Company Details
11.8.2 Sarepta Therapeutics, Inc. Business Overview
11.8.3 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Introduction
11.8.4 Sarepta Therapeutics, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.8.5 Sarepta Therapeutics, Inc. Recent Development
11.9 Scholar Rock, Inc.
11.9.1 Scholar Rock, Inc. Company Details
11.9.2 Scholar Rock, Inc. Business Overview
11.9.3 Scholar Rock, Inc. Growth/Differentiation Factor 8 Introduction
11.9.4 Scholar Rock, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021)
11.9.5 Scholar Rock, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Growth/Differentiation Factor 8 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OSX-200
Table 3. Key Players of SRK-015
Table 4. Key Players of ACE-2494
Table 5. Key Players of ACE-2798
Table 6. Key Players of BMS-986089
Table 7. Key Players of Others
Table 8. Global Growth/Differentiation Factor 8 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Growth/Differentiation Factor 8 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Growth/Differentiation Factor 8 Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Growth/Differentiation Factor 8 Market Share by Regions (2016-2021)
Table 12. Global Growth/Differentiation Factor 8 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Growth/Differentiation Factor 8 Market Share by Regions (2022-2027)
Table 14. Growth/Differentiation Factor 8 Market Trends
Table 15. Growth/Differentiation Factor 8 Market Drivers
Table 16. Growth/Differentiation Factor 8 Market Challenges
Table 17. Growth/Differentiation Factor 8 Market Restraints
Table 18. Global Growth/Differentiation Factor 8 Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Growth/Differentiation Factor 8 Market Share by Players (2016-2021)
Table 20. Global Top Growth/Differentiation Factor 8 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth/Differentiation Factor 8 as of 2020)
Table 21. Ranking of Global Top Growth/Differentiation Factor 8 Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Growth/Differentiation Factor 8 Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Growth/Differentiation Factor 8 Product Solution and Service
Table 25. Date of Enter into Growth/Differentiation Factor 8 Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Growth/Differentiation Factor 8 Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Growth/Differentiation Factor 8 Revenue Market Share by Type (2016-2021)
Table 29. Global Growth/Differentiation Factor 8 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Growth/Differentiation Factor 8 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Growth/Differentiation Factor 8 Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Growth/Differentiation Factor 8 Revenue Market Share by Application (2016-2021)
Table 33. Global Growth/Differentiation Factor 8 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Growth/Differentiation Factor 8 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Growth/Differentiation Factor 8 Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Growth/Differentiation Factor 8 Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Growth/Differentiation Factor 8 Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Growth/Differentiation Factor 8 Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Growth/Differentiation Factor 8 Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Growth/Differentiation Factor 8 Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Growth/Differentiation Factor 8 Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Growth/Differentiation Factor 8 Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Growth/Differentiation Factor 8 Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Growth/Differentiation Factor 8 Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Growth/Differentiation Factor 8 Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Growth/Differentiation Factor 8 Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Growth/Differentiation Factor 8 Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Growth/Differentiation Factor 8 Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Growth/Differentiation Factor 8 Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Growth/Differentiation Factor 8 Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Growth/Differentiation Factor 8 Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Growth/Differentiation Factor 8 Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Growth/Differentiation Factor 8 Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Growth/Differentiation Factor 8 Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Growth/Differentiation Factor 8 Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Growth/Differentiation Factor 8 Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Growth/Differentiation Factor 8 Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Growth/Differentiation Factor 8 Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Growth/Differentiation Factor 8 Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Growth/Differentiation Factor 8 Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Growth/Differentiation Factor 8 Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Growth/Differentiation Factor 8 Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Growth/Differentiation Factor 8 Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Growth/Differentiation Factor 8 Market Size by Country (2022-2027) & (US$ Million)
Table 65. Acceleron Pharma, Inc. Company Details
Table 66. Acceleron Pharma, Inc. Business Overview
Table 67. Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Product
Table 68. Acceleron Pharma, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 69. Acceleron Pharma, Inc. Recent Development
Table 70. Atara Biotherapeutics, Inc. Company Details
Table 71. Atara Biotherapeutics, Inc. Business Overview
Table 72. Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Product
Table 73. Atara Biotherapeutics, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 74. Atara Biotherapeutics, Inc. Recent Development
Table 75. Bristol-Myers Squibb Company Company Details
Table 76. Bristol-Myers Squibb Company Business Overview
Table 77. Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Product
Table 78. Bristol-Myers Squibb Company Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 79. Bristol-Myers Squibb Company Recent Development
Table 80. Eli Lilly and Company Company Details
Table 81. Eli Lilly and Company Business Overview
Table 82. Eli Lilly and Company Growth/Differentiation Factor 8 Product
Table 83. Eli Lilly and Company Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 84. Eli Lilly and Company Recent Development
Table 85. Milo Biotechnology LLC Company Details
Table 86. Milo Biotechnology LLC Business Overview
Table 87. Milo Biotechnology LLC Growth/Differentiation Factor 8 Product
Table 88. Milo Biotechnology LLC Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 89. Milo Biotechnology LLC Recent Development
Table 90. Pfizer Inc. Company Details
Table 91. Pfizer Inc. Business Overview
Table 92. Pfizer Inc. Growth/Differentiation Factor 8 Product
Table 93. Pfizer Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 94. Pfizer Inc. Recent Development
Table 95. Regeneron Pharmaceuticals, Inc. Company Details
Table 96. Regeneron Pharmaceuticals, Inc. Business Overview
Table 97. Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Product
Table 98. Regeneron Pharmaceuticals, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 99. Regeneron Pharmaceuticals, Inc. Recent Development
Table 100. Sarepta Therapeutics, Inc. Company Details
Table 101. Sarepta Therapeutics, Inc. Business Overview
Table 102. Sarepta Therapeutics, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 103. Sarepta Therapeutics, Inc. Recent Development
Table 104. Scholar Rock, Inc. Company Details
Table 105. Scholar Rock, Inc. Business Overview
Table 106. Scholar Rock, Inc. Growth/Differentiation Factor 8 Product
Table 107. Scholar Rock, Inc. Revenue in Growth/Differentiation Factor 8 Business (2016-2021) & (US$ Million)
Table 108. Scholar Rock, Inc. Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Growth/Differentiation Factor 8 Market Share by Type: 2020 VS 2027
Figure 2. OSX-200 Features
Figure 3. SRK-015 Features
Figure 4. ACE-2494 Features
Figure 5. ACE-2798 Features
Figure 6. BMS-986089 Features
Figure 7. Others Features
Figure 8. Global Growth/Differentiation Factor 8 Market Share by Application: 2020 VS 2027
Figure 9. Becker Muscular Dystrophy Case Studies
Figure 10. Fibrosis Case Studies
Figure 11. Myelofibrosis Case Studies
Figure 12. Sickle Cell Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Growth/Differentiation Factor 8 Report Years Considered
Figure 15. Global Growth/Differentiation Factor 8 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Growth/Differentiation Factor 8 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Growth/Differentiation Factor 8 Market Share by Regions: 2020 VS 2027
Figure 18. Global Growth/Differentiation Factor 8 Market Share by Regions (2022-2027)
Figure 19. Global Growth/Differentiation Factor 8 Market Share by Players in 2020
Figure 20. Global Top Growth/Differentiation Factor 8 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Growth/Differentiation Factor 8 as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Growth/Differentiation Factor 8 Revenue in 2020
Figure 22. Global Growth/Differentiation Factor 8 Revenue Market Share by Type (2016-2021)
Figure 23. Global Growth/Differentiation Factor 8 Revenue Market Share by Type (2022-2027)
Figure 24. North America Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Growth/Differentiation Factor 8 Market Share by Type (2016-2027)
Figure 26. North America Growth/Differentiation Factor 8 Market Share by Application (2016-2027)
Figure 27. North America Growth/Differentiation Factor 8 Market Share by Country (2016-2027)
Figure 28. United States Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Growth/Differentiation Factor 8 Market Share by Type (2016-2027)
Figure 32. Europe Growth/Differentiation Factor 8 Market Share by Application (2016-2027)
Figure 33. Europe Growth/Differentiation Factor 8 Market Share by Country (2016-2027)
Figure 34. Germany Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Growth/Differentiation Factor 8 Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Growth/Differentiation Factor 8 Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Growth/Differentiation Factor 8 Market Share by Region (2016-2027)
Figure 44. China Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Growth/Differentiation Factor 8 Market Share by Type (2016-2027)
Figure 52. Latin America Growth/Differentiation Factor 8 Market Share by Application (2016-2027)
Figure 53. Latin America Growth/Differentiation Factor 8 Market Share by Country (2016-2027)
Figure 54. Mexico Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Growth/Differentiation Factor 8 Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Growth/Differentiation Factor 8 Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Growth/Differentiation Factor 8 Market Share by Country (2016-2027)
Figure 60. Turkey Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Growth/Differentiation Factor 8 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Acceleron Pharma, Inc. Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 64. Atara Biotherapeutics, Inc. Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 67. Milo Biotechnology LLC Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 68. Pfizer Inc. Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 69. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 70. Sarepta Therapeutics, Inc. Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 71. Scholar Rock, Inc. Revenue Growth Rate in Growth/Differentiation Factor 8 Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---